Watchlist Price Alert

Stem Inc. (STEM)

NYSE: STEM · Real-Time Price · USD

0.54

-0.01 (-2.26%)

At close: May 09, 2025, 3:59 PM

0.54

1.49%

After-hours: May 09, 2025, 05:59 PM EDT

-2.26% (1D)

Bid	0.52
Market Cap	89.32M
Revenue (ttm)	151.63M
Net Income (ttm)	-806.71M
EPS (ttm)	-4.98
PE Ratio (ttm)	-0.11
Forward PE	-1.48
Analyst	Hold

Ask	0.55
Volume	2,856,826
Avg. Volume (20D)	4,984,739
Open	0.56
Previous Close	0.55
Day's Range	0.52 - 0.57
52-Week Range	0.29 - 1.68
Beta	1.43

About STEM

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol STEM

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for STEM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Stem has released their quartely earnings on Apr 29, 2025:

Revenue of $32.51M exceeds estimates by $2.45M, with 27.65% YoY growth.

EPS of -0.15 exceeds estimates by 0.04, with 67.39% YoY growth.

Why Price Moved

1 week ago

+30.34%

Stem shares are trading higher after the company r... Unlock content with Pro Subscription

3 weeks ago

-10.18%

Shares of companies within the broader industrial sector are trading lower amid overall market weakness after Fed Chair Powell made remarks at the Economic Club. Stocks across sectors may also be weighed down on trade tension fears after after the United States informed NVIDIA that it may require a license to export chips to China.

News

2 days ago · zacks.com

Here Is Why Bargain Hunters Would Love Fast-paced Mover Stem (STEM)

Stem (STEM) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading a...

4 days ago · zacks.com

Renewable Energy & Battery Storage Stocks to Add to Your Portfolio Now

As industries are increasingly adopting renewable energy, demand for energy storage solutions is surging. You may consider buying DTE, BEP, BE & STEM.

3 days ago · businesswire.com

FDA Accepts Resubmission of BLA for Narsoplimab for Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TA-TMA) and Assigns Late September PDUFA Date

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmission of the Biologics License Applicati...

1 week ago · zacks.com

Stem, Inc. (STEM) Reports Q1 Loss, Tops Revenue Estimates

Stem, Inc. (STEM) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.46 per share a year ago.

1 week ago · seekingalpha.com

Stem, Inc. (STEM) Q1 2025 Earnings Call Transcript

Stem, Inc. (NYSE:STEM ) Q1 2025 Earnings Conference Call April 29, 2025 5:00 PM ET Company Participants Ted Durbin - Head, IR Arun Narayanan - CEO Doran Hole - CFO and EVP Conference Call Participants...

1 week ago · businesswire.com

Stem Announces First Quarter 2025 Results

SAN FRANCISCO--(BUSINESS WIRE)--Stem, Inc. announces financial results for the three months ended March 31, 2025.

2 weeks ago · zacks.com

Stem to Report Q1 Earnings: What's in the Cards for the Stock?

STEM's first-quarter 2025 performance is expected to have benefited from PowerTrack momentum and cost cuts amid continued weakness in hardware sales.

1 month ago · businesswire.com

Stem Announces First Quarter 2025 Results Conference Call

SAN FRANCISCO--(BUSINESS WIRE)--Stem, Inc. (NYSE: STEM), a global leader in artificial intelligence (AI)-driven clean energy solutions and services, will hold a conference call on Tues., April 29, 202...

1 month ago · accessnewswire.com

International Stem Cell Corporation Announces 2024 Fourth Quarter and Year-End Results

SAN DIEGO, CA / ACCESS Newswire / March 31, 2025 / International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotech...

1 month ago · zacks.com

Stem Drops 13% in a Month: Are the Shares Worth Buying on the Dip?

STEM drives growth with AI-powered energy solutions, expanding global reach, high-margin software and a strong focus on cost optimization for 2025.

Load More News